Managed Care Pharmacy Issues

AMCP Unscripted discusses a new, non-pharmacological treatment for Chronic Idiopathic Constipation with Dr. Christine Frissora, gastroenterologist and associate professor of clinical medicine, at The NY Presbyterian Cornell University Medical Center and Dr. Ken Schaecher, chief medical officer emeritus, University of Utah Health Plans and chief medical officer at a regional health plan and practicing general internal medicine specialist.

Read the Journal of Managed Care + Specialty Pharmacy (JMCP) May 2025 Issue

Hemophilia is a disorder where the blood does not clot properly. This is due to the body not having enough blood-clotting proteins. This can lead to spontaneous bleeding as well as bleeding following injuries or surgery. They are two types of hemophilia. Hemophilia A and Hemophilia B. Hemophilia A is caused by the lack of low level or clotting factor VIII. Hemophilia B is caused by the lack or low level of clotting factor IX.

Read the Journal of Managed Care + Specialty Pharmacy (JMCP) April 2025 Issue

A coalition of 34 scientific and medical organizations led by the American Association of Immunologists and the American College of Physicians released the following statement.

The Emerging Trends in Managed Care Pharmacy report is part of a larger AMCP Foundation initiative to facilitate deep discussions between health care stakeholders about managed care emerging trends, with a focus on providing opportunities to collaborate on solutions.

In this episode of Unscripted, the AMCP Podcast, we welcome Casey Koch, PharmD, Clinical Pharmacy Coordinator at Select Health. Join us as we explore the evolving landscape of inflammatory bowel disease (IBD), including the latest treatment advancements, guideline updates, and the role of managed care pharmacy in optimizing patient outcomes. From biologics to biosimilars, personalized medicine, and health disparities, we dive deep into the complexities of IBD management and what the future holds for patients and providers alike.

Read the Journal of Managed Care + Specialty Pharmacy (JMCP) March 2025 Issue

AMCP encourages schools and colleges of pharmacy to ensure the provision of a balanced, general education, including information regarding emerging technologies and health care systems, to graduate educated and competent health care professionals.

Stay ahead of industry shifts with insights from the AMCP Foundation’s Emerging Trends Initiative. Published in JMCP, this report explores key developments in technology, therapeutics, payment models, pharmacy operations, and policy. Learn how these trends impact managed care pharmacy professionals and what they mean for you and your business.

Read the Journal of Managed Care + Specialty Pharmacy (JMCP) February 2025 Issue

The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to provide feedback on the “Medicare $2 Drug List Model” issued by CMS.